BABA vs MRSN · P/E 20, rev $148.40B vs rev $40.5M
Alibaba Group Holding Ltd (BABA) versus Mersana Therapeutics Inc (MRSN) — a side-by-side from cached financials, not a winner call.
Alibaba Group Holding Ltd (BABA) is a internet retail company listed on US.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
Latest reported BABA revenue for 2026-03-31 was $148.40B. Net income was $15.02B. Revenue was up 8.1% from 2025-03-31 to 2026-03-31. BABA currently screens at market cap $305.19B and trailing P/E 19.6.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
BABA currently screens at market cap $305.19B and trailing P/E 19.6. MRSN currently screens at market cap $145.4M.
Not investment advice. Open the BABA and MRSN stock pages for the full models.
Not investment advice.